The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
The FDA stated in a release on Friday, "FluMist is approved for the prevention of influenza disease caused by influenza virus ...
FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...
In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...
A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...
What to know about the "optimal time" to get vaccinated against the flu — and how the FluMist nasal spray stacks up to the traditional shot.